7.22
Terns Pharmaceuticals Inc Azioni (TERN) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | - |
Costs And Expenses |
0.16%
27.38
|
27.43 | 25.95 | 24.94 | 25.54 |
Operating Income/Loss |
0.16%
-27.38
|
-27.43 | -25.95 | -24.94 | -25.54 |
Nonoperating Income/Loss |
7.01%
3.354
|
3.607 | 4.19 | 3.056 | 2.862 |
Income/Loss From Continuing Operations Before Tax |
0.88%
-24.03
|
-23.82 | -21.76 | -21.88 | -22.68 |
Income Tax Expense/Benefit |
27.27%
0.064
|
0.088 | 0.04 | 0.062 | 0.061 |
Income/Loss From Continuing Operations After Tax |
0.77%
-24.09
|
-23.91 | -21.80 | -21.95 | -22.74 |
|
0.77%
-24.09
|
-23.91 | -21.80 | -21.95 | -22.74 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.11%
91.58
|
91.47 | 3.9396 | 77.82 | 74.46 |
Diluted Average Shares |
0.11%
91.58
|
91.47 | 3.9396 | 77.82 | 74.46 |
Basic Earnings Per Share |
0.00%
-0.26
|
-0.26 | -0.23 | -0.28 | -0.31 |
Diluted Earnings Per Share |
0.00%
-0.26
|
-0.26 | -0.23 | -0.28 | -0.31 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):